🇪🇺 Imitrex in European Union

Imitrex (SUMATRIPTAN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002140
  • Local brand name: Sumatriptan Galpharm
  • Status: refused

Imitrex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in European Union

Frequently asked questions

Is Imitrex approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Imitrex in European Union?

GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.